Clinical Trial Update: Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on memory T-cell infusion after TCR-alpha/beta depleted hematopoietic stem cell transplantation, with Phase 1/2 status and completion note…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Bone Marrow Failure Syndrome
• Graft-versus-host Disease
• Immunodeficiency
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Memory T-cell infusion (Memory T-cell infusion)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED